Teva’s full-year sales hit $15.9 billion in 2021, down about 6% from 2020. Fourth-quarter revenues came in at $4.1 billion, 8% less than the $4.45 billion Teva made for the last three months of ...

Teva and Takeda's Japanese venture will offload most of its generics portfolio and a manufacturing site to Nichi-Iko Pharmaceutical as the partners "shift focus" to a smaller core of specialty ...

Teva Pharmaceuticals will pay up to $4.25 billion in a nationwide settlement over its alleged role in the opioid crisis. The drug giant announced Tuesday that the settlement with several state and ...

Teva Pharmaceuticals agreed to pay more than $200 million in fines and divest a key generic drug treating cholesterol to settle price-fixing charges from the US Department of Justice, the agency ...

Teva's second-quarter profit of 61 cents per share beat LSEG estimates of 57 cents. The company lifted its annual revenue forecast for Austedo by $100 million to about $1.6 billion.